Enrofloxacin shifts intestinal microbiota and metabolic profiling and hinders recovery from Salmonella enterica subsp. enterica serovar Typhimurium infection in neonatal chickens
B.-H. Ma, X. Mei, C.-W. Lei, C. Li, Y.-F. Gao, L. H. Kong, X. Zhai, H.-N. Wang
This study shows that enrofloxacin treatment in neonatal chickens alters intestinal microbiota and metabolome, leading to prolonged Salmonella Typhimurium infection and hindered recovery.
mSphere · Oct 28, 2020Peer-reviewedMicrobiology